EP3018096B1 - Composite material and method for producing composite material - Google Patents

Composite material and method for producing composite material Download PDF

Info

Publication number
EP3018096B1
EP3018096B1 EP14820599.0A EP14820599A EP3018096B1 EP 3018096 B1 EP3018096 B1 EP 3018096B1 EP 14820599 A EP14820599 A EP 14820599A EP 3018096 B1 EP3018096 B1 EP 3018096B1
Authority
EP
European Patent Office
Prior art keywords
apatite
apatite crystal
tube
composite material
monocrystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP14820599.0A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3018096A4 (en
EP3018096A1 (en
Inventor
Kiminori Enomoto
Hisayoshi Daicho
Yu Shinomiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koito Manufacturing Co Ltd
Original Assignee
Koito Manufacturing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koito Manufacturing Co Ltd filed Critical Koito Manufacturing Co Ltd
Publication of EP3018096A1 publication Critical patent/EP3018096A1/en
Publication of EP3018096A4 publication Critical patent/EP3018096A4/en
Application granted granted Critical
Publication of EP3018096B1 publication Critical patent/EP3018096B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L27/425—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of phosphorus containing material, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/14—Phosphorus; Compounds thereof
    • B01J27/185—Phosphorus; Compounds thereof with iron group metals or platinum group metals
    • B01J27/1856—Phosphorus; Compounds thereof with iron group metals or platinum group metals with platinum group metals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J35/00—Catalysts, in general, characterised by their form or physical properties
    • B01J35/30—Catalysts, in general, characterised by their form or physical properties characterised by their physical properties
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J35/00—Catalysts, in general, characterised by their form or physical properties
    • B01J35/30—Catalysts, in general, characterised by their form or physical properties characterised by their physical properties
    • B01J35/39—Photocatalytic properties
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/455—Phosphates containing halogen
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/10—Inorganic compounds or compositions
    • C30B29/14—Phosphates
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/60—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape characterised by shape
    • C30B29/602—Nanotubes
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/60—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape characterised by shape
    • C30B29/66—Crystals of complex geometrical shape, e.g. tubes, cylinders
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • C30B7/10—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by application of pressure, e.g. hydrothermal processes
    • C30B7/105—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by application of pressure, e.g. hydrothermal processes using ammonia as solvent, i.e. ammonothermal processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/14—Phosphorus; Compounds thereof
    • B01J27/16—Phosphorus; Compounds thereof containing oxygen, i.e. acids, anhydrides and their derivates with N, S, B or halogens without carriers or on carriers based on C, Si, Al or Zr; also salts of Si, Al and Zr
    • B01J27/18—Phosphorus; Compounds thereof containing oxygen, i.e. acids, anhydrides and their derivates with N, S, B or halogens without carriers or on carriers based on C, Si, Al or Zr; also salts of Si, Al and Zr with metals other than Al or Zr
    • B01J27/1802—Salts or mixtures of anhydrides with compounds of other metals than V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, e.g. phosphates, thiophosphates
    • B01J27/1806—Salts or mixtures of anhydrides with compounds of other metals than V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, e.g. phosphates, thiophosphates with alkaline or alkaline earth metals
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/10—Particle morphology extending in one dimension, e.g. needle-like
    • C01P2004/13—Nanotubes

Definitions

  • the present invention relates to crystalline apatites finding application in broad-ranging fields as functional materials as outlined in the preamble of claim 1.
  • Non-Patent Document 1 A known example of apatite-based crystals of this sort is apatite monocrystals in the form of solid hexagonal prisms (Non-Patent Document 1). Also, a method of using needlelike hydroxyapatite whiskers to isolate proteins has been proposed (reference is made to Patent Document 1).
  • Patent Document 1 refers to the document JP9-169794 .
  • Non-Patent Document 1 refers to the article " Direct growth of highly crystalline, idiomorphic fluoroapatite crystals on a polymer substrate", Crystal Growth & Design, 2009, Vol. 9, No. 9, pp. 3832-3834 from Katsuya Teshima et al.
  • Patent Document JP-H07-196314 discloses a composite material according to the preamble of claim 1; YAN ZHOU ET AL: "Single-crystal microtubes of a novel apatite-type compound ......", CRYSTENGCOMM, vol. 11, no.
  • Patent Document JP H09 95787 describes a composite material of apatite and metal sintered to be use as a bone reinforcing material.
  • apatite-based materials In finding application in a variety of uses, apatite-based materials have room for improvement in terms of their form and constituents suited to those uses.
  • the present invention addresses this situation and a purpose thereof is to afford a novel composite material having tubular apatite crystals.
  • a composite material according to an embodiment of the present invention comprises the characterizing features of claim 1.
  • This embodiment yields novel functionality that cannot be obtained from tubular apatite crystal alone.
  • the apatite crystal may be a monocrystal given by the general formula M 2 5 (PO 4 ) 3 X , where M 2 denotes at least one element selected from the group consisting of divalent alkali earth metals and Eu, and X denotes at least one element or molecule selected from the group consisting of halogen elements and OH.
  • M 2 denotes at least one element selected from the group consisting of divalent alkali earth metals and Eu
  • X denotes at least one element or molecule selected from the group consisting of halogen elements and OH.
  • the transmittance of the apatite crystal to visible light may be 65% or higher.
  • the functional component is in the context of the claimed invention constituted by a material more rigid than the apatite crystal. This realizes strength that is difficult to obtain from apatite crystal alone.
  • the functional part may be constituted by a photocatalytic substance. Placing the photocatalytic substance inside the tubular apatite crystal realizes a photocatalytic material of improved performance.
  • the functional part may be constituted by an enzyme. This allows the composite material to be used as, for example, a bioreactor.
  • the apatite crystal may be a hexagonal prism in outer form, and a hole-opening formed in either of top or bottom surfaces of the hexagonal prism may be of hexagonal form.
  • the apatite crystal has, in the context of the claimed invention, a tube-hole inner diameter of at least 0.5 ⁇ m, for example of 0.5 ⁇ m to 800 ⁇ m.
  • the apatite crystal may be 1 ⁇ m - 1 mm in diameter.
  • the apatite crystal may measure 2 ⁇ m - 4 mm lengthwise.
  • Another embodiment of the present invention relates to a method of manufacturing a composite material.
  • the method comprises: placing, tube-internally in an apatite crystal in the form of a tube, a metallic material of rigidity higher than that of the apatite crystal; and fusing and immobilizing the metallic material with a laser beam transmitted through the apatite crystal.
  • the metallic material can be easily immobilized inside the apatite crystal tube.
  • the metallic material may be a single kind of metal or an alloy. Still alternatively, the metallic material may contain a substance other than metal. The fusing point of the metal material is lower than that of the apatite crystal.
  • An alternative method not forming part of the claimed invention relates to a method of manufacturing a composite material.
  • the method comprises: adsorbing avidin molecules tube-internally into an apatite crystal in the form of a tube; and infusing the tube interior with a solution containing a biotin-labeled enzyme to immobilize the enzyme inside the tube.
  • an enzyme can be easily immobilized in the apatite crystal tube.
  • a novel composite material containing a tubular apatite is provided.
  • the apatite crystal according to an embodiment is a tubular apatite monocrystal.
  • the apatite crystal is given by a general formula M 2 5 (PO 4 ) 3 X (M 2 denotes at least one element selected from the group consisting of a divalent alkali earth metal and Eu, and X denotes at least one element or molecule selected from the group consisting of a halogen element and OH).
  • M 2 denotes at least one element selected from the group consisting of a divalent alkali earth metal and Eu
  • X denotes at least one element or molecule selected from the group consisting of a halogen element and OH.
  • the alkali earth metal may be Ca, Sr, Ba, Ra, Mg, or Be.
  • the halogen element may be, for example, F, CI, Br, or I.
  • Examples 1-7 are directed to a method of synthesizing a chlorapatite monocrystal.
  • Examples 8-10 are directed to a method of synthesizing a hydroxyapatite monocrystal. Synthesizing methods include the flux method, coprecipitation method, sol-gel method, etc.
  • the mixture is heated to 800-1100°C in a platinum crucible at a temperature increase rate 100-500°C/h. Synthesis is allowed to proceed for 48 hours at a synthesis temperature of 800-1100°C and then the temperature is lowered from 800-1100°C to 500°C at a temperature decrease rate 5-300°C/h. Thereafter, the synthesized product is cooled naturally to a normal temperature. After calcination, the product is cleaned carefully using pure hot water (about 80°C) to extract a chlorapatite monocrystal.
  • the mixture is heated to 800-1100°C in a platinum crucible at a temperature increase rate 100-500°C/h. Synthesis is allowed to proceed for 48 hours at a synthesis temperature of 800-1100°C and then the temperature is lowered from 800-1100°C to 500°C at a temperature decrease rate 5-300°C/h. Thereafter, the synthesized product is cooled naturally to a normal temperature. After calcination, the product is cleaned carefully using pure hot water (about 80°C) to extract a chlorapatite monocrystal.
  • SrCl 2 is added so that the chlorapatite concentration is 0.15 mol%.
  • the mixture is heated to 800-1100°C in a platinum crucible at a temperature increase rate 100-500°C/h. Synthesis is allowed to proceed for 48 hours at a synthesis temperature of 800-1100°C and then the temperature is lowered from 800-1100°C to 500°C at a temperature decrease rate 5-300°C/h. Thereafter, the synthesized product is cooled naturally to a normal temperature. After calcination, the product is cleaned carefully using pure hot water (about 80°C) to extract a chlorapatite monocrystal.
  • MgCl 2 is added so that the chlorapatite concentration is 0.15 mol%.
  • the mixture is heated to 800-1100°C in a platinum crucible at a temperature increase rate 100-500°C/h. Synthesis is allowed to proceed for 48 hours at a synthesis temperature of 800-1100°C and then the temperature is lowered from 800-1100°C to 500°C at a temperature decrease rate 5-300°C/h. Thereafter, the synthesized product is cooled naturally to a normal temperature. After calcination, the product is cleaned carefully using pure hot water (about 80°C) to extract a chlorapatite monocrystal.
  • a 0.5 mol/L aqueous solution of phosphoric acid is dropped in a 0.3 mol/L suspended calcium hydrate liquid.
  • a monocrystal precipitate (seed crystal) is obtained by adjusting pH to 5-9 to promote formation of a monocrystal.
  • the seed crystal prepared by the coprecipitation method is allowed to grow by the Czochralski method.
  • Calcium hydrate is heated to 1650°C.
  • the seed crystal is immersed in the resultant high-temperature solution. By pulling up the crystal while cooling the solution gradually from 1650°C to 1000°C, a needle-shaped hydroxyapatite monocrystal is obtained.
  • lactic acid is dissolved in 1 liter of water. 22.11 g of calcium hydrate is then added. Further, 6.92 g of phosphoric acid is dissolved into the mixture.
  • An autoclave is filled with the slurry prepared in this way. The slurry is subject to a hydrothermal process for 5 hours at 165°C. The slurry thus processed is filtered and dried so as to obtain a hydroxyapatite monocrystal.
  • the hydrothermal process is performed in an autoclave of test tube type by using water as a pressure medium under the condition of 100 MPa.
  • the temperature increase rate is 20°C per minute.
  • the processing temperature is constantly 400°C and the processing time is 48 hours. In this way, a hydroxyapatite monocrystal is obtained.
  • the chlorapatite monocrystal (20 mg) is heated 1300°C. Water vapor is introduced in the kiln to induce a reaction over a period of 2 weeks, thereby transforming the chlorapatite monocrystal into a hydroxyapatite monocrystal.
  • Fig. 1 is an exemplary X-ray analysis pattern of the crystal formed by the methods in Examples. As shown in Fig. 1 , the crystal comprises a single layer of chlorapatite monocrystal Ca 5 (PO 4 ) 3 Cl.
  • the chlorapatite tube monocrystal was then subject to element analysis.
  • Fig. 2 is a photograph of an exemplary chlorapatite tube monocrystal observed by the SEM.
  • the apatite monocrystal according to the embodiment is tubular and the outer form of the crystal is a hexagonal prism. Further, the aperture of the hole formed on the top surface or bottom surface of the hexagonal prism is hexagonal in shape. For this reason, the thickness of the tube outer wall is substantially uniform.
  • the tubular monocrystals are in various sizes and forms.
  • the inner diameter of the hole of the opening of the tubular monocrystal is about 3 nm - 800 ⁇ m, and, preferably, about 10 nm - 60 ⁇ m.
  • the diameter of the tubular monocrystal is about 20 nm - 1 ⁇ m.
  • the length of the tubular monocrystal in the longitudinal direction is about 50 nm - 4 mm.
  • the transmittance of the tubular monocrystal to visible light is 65% or higher.
  • a tubular apatite monocrystal to a reinforcing material for an artificial bone. More specifically, we devised a composite material in which a tubular monocrystal of apatite as a biomaterial is used, as a reinforcing member for improving the strength of an artificial bone. Unlike the related-art solid needle-shaped apatite crystal, a tubular apatite crystal can receive a strong metal such as titanium inserted into the tube. Therefore, higher strength than the related-art reinforcing member can be obtained.
  • aspects of the performance required of a reinforcing member for use in an artificial bone are (i) high biocompatibility and (ii) high strength.
  • a high aspect ratio needle-shaped apatite as a biomaterial when used as a reinforcing member, has low strength and so is insufficient as a reinforcing member for an artificial bone used in a movable region.
  • a reinforcing member having high biocompatibility and having a higher strength than the related-art biomaterial apatite has been called for.
  • the diameter of the apatite monocrystal of a hollow (tubular) hexagonal prism shape in an application like this is about 1 ⁇ m - 1 mm.
  • the inner diameter of the hole of the opening of the tubular monocrystal is at least 0.5 ⁇ m, for example, about 0.5 ⁇ m - 800 ⁇ m.
  • the length of the tubular monocrystal in the longitudinal direction is, for example, about 2 ⁇ m - 4 mm.
  • a tubular hydroxyapatite monocrystal having a length of 200 ⁇ m, a diameter of 40 ⁇ m, and an inner diameter of 20 ⁇ m of the hole of the opening was obtained according to the method described in Example 1 or Example 12.
  • the apatite monocrystal is a substance that transmits visible light.
  • An aluminum wire was inserted into the hollow portion of the tubular hydroxyapatite monocrystal thus obtained.
  • the aluminum wire was immobilized inside the tube by heating wire locally from outside for 1 hour at about 700°C, using a YAG laser, thereby producing a reinforcing member.
  • the visible light transmittance of the tubular apatite monocrystal is 65% or higher. Since the tubular apatite monocrystal is transparent, laser light is transmitted through the crystal to heat the aluminum wire selectively. Accordingly, the damage exerted by the heat of the laser on the apatite monocrystal is reduced.
  • the method of manufacturing a composite material (reinforcing member) places, tube-internally in tubular apatite crystal, a metal material (titanium, aluminum, magnesium, an alloy thereof, etc.) more rigid than the apatite crystal, and fuses and immobilizes the metal material by laser light transmitted through the apatite crystal.
  • the metal material can be easily immobilized in the apatite crystal tube.
  • the metal material may be a single kind of metal (titanium, aluminum, magnesium, etc.) or an alloy thereof.
  • the metal material may contain a substance other than metal.
  • the fusing point of the metal material is lower than that of the apatite crystal. In this case, the metal material may be fused selectively without fusing the apatite monocrystal.
  • a tubular apatite monocrystal is used in the composite material describes above.
  • a needle-shaped apatite monocrystal is used. More specifically, a 0.5 mol/L aqueous solution of phosphoric acid was dropped in a 0.3 mol/L suspended calcium hydrate liquid. A monocrystal precipitate was obtained by adjusting pH to 5-9 to promote formation of a monocrystal. A needle-shaped hydroxyapatite monocrystal having a length of 200 ⁇ m and an outer diameter of 40 ⁇ m was obtained by allowing the precipitate to grow at 1200°C for 48 hours.
  • a pulsed current sintering device was used to sinter CaO as an air cell control material at 700°C for 10 minutes.
  • the CaO sintered compact was coarsely ground and classified to isolate powders of about 100 - 200 ⁇ m.
  • the spherical hydroxyapatite powders having an average particle diameter of 10 ⁇ m and the classified air cell control material were mixed uniformly.
  • the blend ratio of the air cell control material is 50 vol%. Stoichometrically, the Ca/P ratio in hydroxyapatite is 1.67.
  • the break strength [MPa] in Table 1 represents a breaking stress (load per unit area) in a phenomenon where a solid-state material is broken into two or more parts under an external force.
  • the break strength represents a measurement of J toughness value determined by measuring the three-point strength in accordance with Japanese Industrial Standard (JIS).
  • KIC Fracture toughness [MPa*m 1/2 ] is a stress intensity factor required for a crack to develop.
  • a test piece of the same size as the test piece for break strength measurement was used.
  • a diamond cutter was used to form a U groove having a width of 0.1 mm and a depth of 0.75 mm at the center of the test piece. Measurements were made at room temperature at a span of 30 mm and at a cross head speed of 0.75 mm/min, and KIC was determined according to the following equation.
  • KIC Y ⁇ a 1 / 2 where Y: form factor, a: bending strength, a: crack length.
  • Breaking energy is defined as a total energy exerted on the material before breakage.
  • a material with a large breaking energy is referred to as "rigid”. Breaking energy was calculated from the area formed by the stress-distortion curve obtained in a fracture toughness test and the cross sectional area of fractured surface of the test piece.
  • the break strength, breaking energy, and fracture toughness value of an artificial bone reinforced by the composite material (inventive example) produced by filling a tubular apatite monocrystal by a metal material are all higher than those of an artificial bone in which a needle-shaped apatite monocrystal (comparative example) is added.
  • the strength that can hardly be obtained with an apatite crystal alone is realized by forming the functional part by a material more rigid than the apatite crystal.
  • the composite material according to the first embodiment is suitable as a reinforcing member.
  • Hydroxyapatite coated with titanium oxide or the like does not contain metal atoms that are harmful to the environment.
  • the hydroxyapatite carrier itself has the capability to adsorb organic substance or the like, and the titanium oxide coating absorbs light ranging from visible light to ultraviolet light. Therefore, excellent photocatalytic activity is exhibited.
  • the apatite coated with a photocatalytic substance in itself is often in powder form for ease of use, etc. If this is used to fill a column, the column is easily clogged so that liquid permeability cannot be secured. Another problem is that the interior of the column cannot be sufficiently irradiated with light.
  • One approach to prevent clogging is to use hydroxyapatite having a large particle diameter. Disadvantageously, however, an increase in particle diameter results in a smaller specific surface area and lower photocatalytic performance.
  • the composite material according to the embodiment can realize excellent photocatalytic applications because the tube-shape of the apatite crystal enlarges the surface area and the formation of a titanium oxide coating on the transparent apatite monocrystal surface activates the photocatalytic reaction induced by the light transmitted through the apatite monocrystal.
  • a description will be given below of a method of manufacturing a composite material according to the embodiment having a photocatalytic function with reference to Example 13 and Example 14.
  • a tubular hydroxyapatite monocrystal having a composition Ca 5 (PO 4 ) 3 (OH), and having a length of 0.3 - 2 mm and an inner diameter of 80 - 300 nm of the hole of the opening was obtained according to the method described in Examples 1-12 above.
  • the monocrystal was immersed in a room-temperature glass coating agent containing 0.1 - 5 wt% of Ti-modified apatite for 1 hour, cleaned in pure water, and dried at 80°C for 12 hours.
  • the monocrystal was annealed for 1 hour at 700°C. A portion of the apatite tube surface is replaced by titanium so as to impart the crystal with photocatalytic function.
  • a tubular chlorapatite monocrystal having a composition Ca 5 (PO 4 ) 3 Cl, and having a length of 0.3 - 2 mm and an inner diameter of 50 - 200 nm of the hole of the opening was obtained according to the method described in Examples 1-12 above.
  • the monocrystal was immersed in a room-temperature glass coating agent containing 0.1 - 5 wt% of Ti-modified apatite for 1 hour, cleaned in pure water, and dried at 80°C for 12 hours.
  • the monocrystal was annealed for 1 hour at 700°C. A portion of the apatite tube surface is replaced by titanium so as to impart the crystal with photocatalytic function.
  • the photocatalytic activity was evaluated, using the composite material obtained according to Example 13 and Example 14 and having photocatalytic function.
  • sample powders of composite materials according to the respective Examples were weighed so as to have a surface area based on specific surface area measurements.
  • the sample thus weighed is used to fill the bottom of a glass container topped by a quartz glass in uniform thickness.
  • the interior of the container is replaced by synthetic air (20 volume % of oxygen, 80 volume % of nitrogen).
  • acetaldehyde is injected into the container so that the acetaldehyde gas concentration is 1 volume %.
  • the mixture is left at rest in a dark place until the acetaldehyde gas reaches adsorption equilibrium with the sample powders.
  • the mixture is started to be irradiated with light from a light source of a xenon lamp (3 hours after the mixture is left at rest in a dark place).
  • the gas is extracted by a cylinder 1 hour after the adsorption equilibrium is reached (2 hours after the mixture is left at rest in a dark place), 2 hours later (3 hours after the mixture is left at rest in a dark place), and 3 hours later (4 hours after the mixture is left at rest in a dark place).
  • the CO 2 gas concentration was measured by using gas chromatography. 2 hours after the mixture was irradiate by light from the light source, a CO 2 gas concentration of 5 g/L (liter) or higher was observed and high photocatalytic activity was exhibited in every sample.
  • a composite material comprised of a tubular apatite crystal as a carrier and a photocatalytic substance as a functional part accommodated in the tube allows the interior of a column closely filled with the composite material to be irradiated with light.
  • gas or liquid can pass through the tube.
  • the tubular apatite crystal has 1.5 - 4 times the specific surface area [cm 2 /g] as compared to the needle-shaped apatite crystal so that the photocatalytic performance is 1.5 - 4 times higher. Since the photocatalytic substance can be placed inside the tubular apatite crystal, the composite material according to the embodiment can exhibit improved photocatalytic performance.
  • enzymes are biocatalysts and functions primarily in vivo. Specificity and selectivity of enzymes are utilized to adsorb or decompose organic substances such as sugar or protein. Enzyme reaction proceeds relatively quickly in an aqueous solution at normal temperature and normal pressure and contributes to chemical industry and instrumental analysis by simplifying reaction routes to synthesize organic substances. Due to its low impact on environment, enzyme reaction could help realize low-carbon society.
  • enzymes used in liquid are basically disposed after use and increase the cost accordingly.
  • One approach to utilize valuable enzymes fruitfully is to create a bioreactor built to immobilize an enzyme in an insoluble carrier, allow the carrier to contact an organic source material, and cause the enzyme to work and function as a catalyst.
  • a tubular apatite monocrystal useful as a biomaterial is used as a carrier to immobilize an enzyme.
  • the adsorption action of apatite is exploited to immobilize the enzyme to form a bioreactor column.
  • the functional part according to this embodiment is formed by an immobilized enzyme.
  • an enzyme and a biotin labeling agent are suspended in a buffered solution (pH8.5) so that the molar ratio of the mixture is 1:2 - 1:10.
  • the mixture, infused with the suspended liquid is then incubated in a constant temperature bath (25°C) for 2-4 hours.
  • the resultant solution is analyzed by chromatography so as to isolate the labeled enzyme.
  • a tubular hydroxyapatite monocrystal having a composition Ca 5 (PO 4 ) 3 (OH), and having a length of 0.3 - 2 mm and an inner diameter of 80 - 600 nm of the hole of the opening was obtained according to the method described in Examples 1-12 above.
  • the apatite tube is then infused with a solution produced by suspending amylase in a buffered solution of pH5-6.5.
  • the composite is incubated in a hot bath of 20-35°C for 8 hours so as to immobilize the amylase in the apatite tube.
  • a tubular chlorapatite monocrystal having a composition Ca 5 (PO 4 ) 3 Cl, and having a length of 0.3 - 2 mm and an inner diameter of 3 - 40 nm of the hole of the opening was obtained according to the method described in Examples 1-12 above.
  • the apatite tube is then infused with a solution produced by suspending glucoamylase in a buffered solution of pH7-9.
  • the composite is incubated in a hot bath of 20-35°C for 8 hours so as to immobilize the glucoamylase in the apatite tube.
  • a tubular chlorapatite monocrystal having a composition Ca 5 (PO 4 ) 3 Cl, and having a length of 0.5 - 4 mm and an inner diameter of 3 - 40 nm of the hole of the opening was obtained according to the method described in Examples 1-12 above.
  • the apatite tube is then infused with a solution produced by dispersing avidin molecules in a buffered solution of pH6-8.
  • the composite is incubated in a hot bath of 20-35°C for 4 hours so as to immobilize the avidin molecules in the apatite tube electrostatically.
  • An enzyme labeled by biotin is then suspended in a buffered solution of pH6-8 and the suspended solution is used to infuse the apatite tube at 20-25°C for 30 minutes, thereby immobilizing the enzyme in the apatite tube by a biotin-avidin reaction.
  • enzymes such as amylase, cellulase, xylase, racemase, etc. that differ in molar weight and isoelectric point can be easily immobilized.
  • FIG. 3 schematically shows a device in which the bioreactor column according to this embodiment is used.
  • a column having an inner diameter of 10 mm and a length of 100 mm was filled with a tubular apatite monocrystal in which glucoamylase is immobilized according to the biotin-avidin method, so as to prepare a bioreactor column 10.
  • a buffered solution containing oligosaccharide and adjusted to pH7-8 was supplied from a source material container 12 to the bioreactor column 10 by using a tube pump 14.
  • the buffered solution was supplied in a continuous steady-state operation at a liquid temperature of 30°C and a liquid measure of 0.3 ml/minute.
  • the solution discharged from the bioreactor column 10 was collected in a sample container 16 at 1 hour intervals.
  • the content of the sample was isolated and identified by thin-layer chromatography. It was revealed that most of the oligosaccharide is decomposed into glucose in the sample solution at all points of time that the sample was collected and that the bioreactor column 10 was functioning sufficiently.
  • the apatite crystal according to the embodiment can be used as a variety of functional materials including fluorescent bodies.
  • bioreactor column 10 bioreactor column, 12 source material container, 14 tube pump, 16 sample container.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Metallurgy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Composite Materials (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Geometry (AREA)
  • Materials For Medical Uses (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Catalysts (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
EP14820599.0A 2013-07-03 2014-06-16 Composite material and method for producing composite material Active EP3018096B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013140067 2013-07-03
PCT/JP2014/003203 WO2015001734A1 (ja) 2013-07-03 2014-06-16 複合材料および複合材料の製造方法

Publications (3)

Publication Number Publication Date
EP3018096A1 EP3018096A1 (en) 2016-05-11
EP3018096A4 EP3018096A4 (en) 2017-05-10
EP3018096B1 true EP3018096B1 (en) 2018-06-13

Family

ID=52143337

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14820599.0A Active EP3018096B1 (en) 2013-07-03 2014-06-16 Composite material and method for producing composite material

Country Status (5)

Country Link
US (1) US10208302B2 (ja)
EP (1) EP3018096B1 (ja)
JP (2) JP6466839B2 (ja)
CN (1) CN105358479B (ja)
WO (1) WO2015001734A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150058388A (ko) * 2012-09-18 2015-05-28 가부시키가이샤 고이토 세이사꾸쇼 흡착 방법, 흡착 분리 방법 및 드러그 딜리버리용 담지체
JP6746117B2 (ja) * 2016-06-15 2020-08-26 株式会社小糸製作所 アパタイト結晶の製造方法
CN114075076A (zh) * 2020-08-17 2022-02-22 厦门稀土材料研究所 一种氯磷灰石陶瓷及其制备方法和应用
WO2023234424A1 (ja) * 2022-06-02 2023-12-07 株式会社小糸製作所 ＤＤＳ（Ｄｒｕｇ Ｄｅｌｉｖｅｒｙ Ｓｙｓｔｅｍ）用担持体およびＤＤＳ用担持体の製造方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01238869A (ja) * 1988-03-18 1989-09-25 Nikon Corp アパタイト系骨内インプラント

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2810138B2 (ja) * 1989-08-23 1998-10-15 昭和電工株式会社 酵素活性測定用充填剤、その使用方法および装置
JPH07196314A (ja) * 1993-12-28 1995-08-01 Maruo Calcium Co Ltd チューブ状合成無機微粒子
JP2975290B2 (ja) * 1995-09-20 1999-11-10 新田ゼラチン株式会社 アパタイト−チタン系複合材料、その製造方法およびその複合材料用組成物
JPH09138234A (ja) * 1995-11-13 1997-05-27 Toagosei Co Ltd 標識化プローブの製造方法
JPH09169794A (ja) 1995-12-22 1997-06-30 Mitsubishi Materials Corp 蛋白質類の分離方法
JP3959564B2 (ja) * 1997-12-24 2007-08-15 村樫石灰工業株式会社 表層から芯部まで多孔質アパタイトに転換された固体物質の製造方法
JP2000095577A (ja) * 1998-09-24 2000-04-04 Asahi Optical Co Ltd ハイドロキシアパタイト−金属複合体の製造方法およびハイドロキシアパタイト−金属複合体
JP2000271488A (ja) * 1999-03-25 2000-10-03 Maruo Calcium Co Ltd 光触媒性ウィスカー及び光触媒性組成物
JP3806061B2 (ja) * 2002-05-21 2006-08-09 富士通株式会社 金属修飾アパタイト含有膜の形成方法、これに用いられるコーティング液、および金属修飾アパタイト含有膜で被覆された部位を有する電子機器
JP2011011971A (ja) * 2009-06-02 2011-01-20 Nittetsu Mining Co Ltd チューブ状リン酸カルシウム及びその製造方法
EP2837715B1 (en) * 2012-04-09 2019-10-16 Koito Manufacturing Co., Ltd. Apatite crystal
KR20150058388A (ko) * 2012-09-18 2015-05-28 가부시키가이샤 고이토 세이사꾸쇼 흡착 방법, 흡착 분리 방법 및 드러그 딜리버리용 담지체

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01238869A (ja) * 1988-03-18 1989-09-25 Nikon Corp アパタイト系骨内インプラント

Also Published As

Publication number Publication date
EP3018096A4 (en) 2017-05-10
US20160102302A1 (en) 2016-04-14
JP6609016B2 (ja) 2019-11-20
US10208302B2 (en) 2019-02-19
JPWO2015001734A1 (ja) 2017-02-23
CN105358479B (zh) 2018-10-09
JP2019026554A (ja) 2019-02-21
WO2015001734A1 (ja) 2015-01-08
JP6466839B2 (ja) 2019-02-06
EP3018096A1 (en) 2016-05-11
CN105358479A (zh) 2016-02-24

Similar Documents

Publication Publication Date Title
JP6609016B2 (ja) 複合材料および複合材料の製造方法
Lin et al. Biomimetic hydroxyapatite porous microspheres with co-substituted essential trace elements: surfactant-free hydrothermal synthesis, enhanced degradation and drug release
KR101639504B1 (ko) 아파타이트 결정
US8153255B2 (en) Ceramic particle group comprising sintered particles of hydroxyapatite
KR101212433B1 (ko) 다공질 세라믹스 재료의 제조 방법
EP3798185A1 (en) Aluminum phosphate compound
Chen et al. Hydrothermal synthesis of hydroxyapatite coatings with oriented nanorod arrays
EP2898944B1 (en) Adsorption separation method by using an apatite crystal
Martínez et al. Production and study of in vitro behaviour of monolithic α-Tricalcium Phosphate based ceramics in the system Ca3 (PO4) 2–Ca2SiO4
Masmoudi et al. Elaboration and properties of new ceramic microfiltration membranes from natural and synthesised apatite
Mokhtari et al. In situ high-temperature X-ray diffraction, FT-IR and thermal analysis studies of the reaction between natural hydroxyapatite and aluminum powder
WO1999038542A1 (en) A synthetic biomaterial compound
Jiang et al. Calcium phosphate with well controlled nanostructure for tissue engineering
Adams et al. Bioactivity of quaternary glass prepared from bentonite clay
Koroglu et al. A novel approach for synthesis of monticellite based bioactive ceramic powders from boron derivative waste
CN101214382A (zh) 一种铕标记羟基磷灰石纳米粒子的制备方法
Nabiyouni et al. Microwave assisted solution combustion synthesis (MASCS) of europium (Eu) doped chlorapatite nanowhiskers
CN111115599A (zh) 离子液体诱导的羟基磷灰石多级纳米棒的制备方法
JP7554424B2 (ja) ユーロピウム化合物の結晶体及びユーロピウム化合物の結晶体の製造方法
Charczuk et al. Multifunctional platform for future applications in cell and tissue engineering based on silicate phosphate hydroxyapatite co-doped with Li+, Eu3+ and Gd3+ ions
WO2020261298A1 (en) Nanodiamond embedded biomolecular glass from egg and method of production of the same
Sugiura et al. Revision 2
Ue et al. The effect of sodium dopants on calcium polyphosphate biomaterials
Van Tran Investigation into the thermal dehydroxylation and decomposition of hydroxylapatite during atmospheric plasma spraying

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160118

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C01B 25/455 20060101ALI20170224BHEP

Ipc: B01J 27/185 20060101ALI20170224BHEP

Ipc: B01J 27/18 20060101ALN20170224BHEP

Ipc: C30B 29/60 20060101ALI20170224BHEP

Ipc: A61L 27/46 20060101ALI20170224BHEP

Ipc: C30B 29/14 20060101ALI20170224BHEP

Ipc: B01J 35/00 20060101ALI20170224BHEP

Ipc: C01B 25/32 20060101AFI20170224BHEP

Ipc: B01J 35/02 20060101ALI20170224BHEP

Ipc: C30B 7/10 20060101ALI20170224BHEP

Ipc: A61L 27/42 20060101ALI20170224BHEP

Ipc: C30B 29/12 20060101ALI20170224BHEP

Ipc: C12N 11/14 20060101ALI20170224BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20170406

RIC1 Information provided on ipc code assigned before grant

Ipc: B01J 35/00 20060101ALI20170401BHEP

Ipc: C12N 11/14 20060101ALI20170401BHEP

Ipc: B01J 35/02 20060101ALI20170401BHEP

Ipc: A61L 27/46 20060101ALI20170401BHEP

Ipc: C30B 29/12 20060101ALI20170401BHEP

Ipc: C30B 29/14 20060101ALI20170401BHEP

Ipc: C01B 25/455 20060101ALI20170401BHEP

Ipc: C01B 25/32 20060101AFI20170401BHEP

Ipc: A61L 27/42 20060101ALI20170401BHEP

Ipc: B01J 27/185 20060101ALI20170401BHEP

Ipc: C30B 29/60 20060101ALI20170401BHEP

Ipc: B01J 27/18 20060101ALN20170401BHEP

Ipc: C30B 7/10 20060101ALI20170401BHEP

17Q First examination report despatched

Effective date: 20171123

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: B01J 27/185 20060101ALI20180112BHEP

Ipc: B01J 35/00 20060101ALI20180112BHEP

Ipc: B01J 35/02 20060101ALI20180112BHEP

Ipc: C01B 25/455 20060101ALI20180112BHEP

Ipc: C12N 11/14 20060101ALI20180112BHEP

Ipc: A61L 27/46 20060101ALI20180112BHEP

Ipc: C30B 29/12 20060101ALI20180112BHEP

Ipc: A61L 27/42 20060101ALI20180112BHEP

Ipc: C30B 7/10 20060101ALI20180112BHEP

Ipc: C01B 25/32 20060101AFI20180112BHEP

Ipc: C30B 29/60 20060101ALI20180112BHEP

Ipc: C30B 29/14 20060101ALI20180112BHEP

Ipc: B01J 27/18 20060101ALN20180112BHEP

INTG Intention to grant announced

Effective date: 20180129

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1008325

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180615

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014027100

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 5

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20180613

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180913

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180913

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180914

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1008325

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180613

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181013

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20180630

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602014027100

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180616

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180630

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180616

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180630

26N No opposition filed

Effective date: 20190314

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180630

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180616

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180613

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180613

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20140616

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20200603

Year of fee payment: 7

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20210616

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210616

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230517

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20230502

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240509

Year of fee payment: 11